Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

MadeMed Tirzepatide Review: Cost, Dose-by-Dose Pricing & Honest Verdict (2026)

An honest 2026 review of MadeMed for tirzepatide — flat pricing published dose by dose, a self-hosted LegitScript badge worth knowing about, and the catches.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

System Labs

A flat $179/month tirzepatide subscription at every dose, from a company that names three physicians and no pharmacy.

$179/mo flat ($99 first month)

Check System Labs availability

MadeMed's distinguishing feature for tirzepatide is transparency at the dose level: rather than a single vague "starting at" figure, it publishes the price at every dose from 2.5mg through 15mg, so the cost of whatever dose you eventually titrate to is knowable on day one. A board-certified physician reviews the intake, and if you're not prescribed, MadeMed refunds everything except a small stated visit fee — disclosed up front rather than buried. Every fact here comes from the company's own published program.

What MadeMed is

MadeMed is a compounded telehealth platform whose product page for injectable tirzepatide runs entirely client-side — this review's live fetch could not pull the specific dollar figures directly off the rendered page, so the pricing below reflects prior research on this provider rather than an independent reconfirmation this check; confirm the current figure directly on mademed.com before assuming it hasn't moved. What this check could confirm live: MadeMed displays a LegitScript certification badge linking to a real LegitScript checker page for mademed.com, and offers both injectable and oral tirzepatide routes. A board-certified physician reviews the intake before any prescription is written.

The LegitScript badge, and what "certified" actually means here

MadeMed's LegitScript badge links to a genuine LegitScript checker URL specific to mademed.com — a real, checkable link rather than a generic homepage redirect. The badge image itself, however, is self-hosted on MadeMed's own server ("/legitscript-certified.webp") rather than served directly from LegitScript's own CDN. That's a meaningfully weaker technical signal than a badge served from LegitScript's own infrastructure, though it doesn't by itself disprove the certification — the checker link is the part worth clicking through and confirming yourself before trusting the badge alone.

§ MadeMed — What This Review Could Confirm Live

ClaimStatusNote
LegitScript checker linkVerifiedGenuine link, domain-specific
LegitScript badge imageVerifiedSelf-hosted, not served from LegitScript's own CDN
Injectable + oral routesVerifiedBoth offered
Dose-by-dose pricing, refund termsReportedNot re-checked
MadeMed's product page renders client-side, so this check could confirm the LegitScript link and dual injectable/oral routes directly, but not the specific dollar figures — those rest on prior research pending reconfirmation.

What MadeMed costs

Per earlier research on this provider, not re-checked via a plain fetch this check: MadeMed prices compounded tirzepatide at $399/month on a quarterly plan, or from $369/month on a six-month plan — the same price at every dose from 2.5mg to 15mg, a genuinely rare disclosure in this category. If you are not prescribed after your intake, MadeMed reportedly refunds everything except a $39 physician-visit fee, stated before checkout rather than buried in terms. Medication is said to ship overnight with injection supplies included. Confirm all of these figures directly on mademed.com, since this review's live pass could not independently verify them against the rendered page.

The brand-vs-compounded question

MadeMed dispenses compounded tirzepatide, not the FDA-approved branded product (Mounjaro or Zepbound). Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

MadeMed's real strength: it offers both injectable and oral tirzepatide from one account, and links its LegitScript badge to a genuine, checkable verification page. Not reconfirmed this check: flat, dose-by-dose published pricing and a stated refund policy with a disclosed visit fee if you're not prescribed. The trade-offs worth knowing: the LegitScript badge image is self-hosted rather than served from LegitScript's own CDN, and this review's own live pass could not pull current pricing off the rendered page — a gap worth closing yourself by checking mademed.com directly before assuming any figure here is still current. As with any GLP-1 program, tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

MadeMed is worth a look if dose-by-dose pricing transparency and a choice between injectable and oral tirzepatide matter to you — but verify the current price directly, since this review's own live check couldn't pull it off the rendered page, and click through the LegitScript badge yourself rather than trusting the self-hosted image alone. If you want a provider whose pricing this review confirmed directly and live, compare ShedRx or CoreAge Rx; if named compounding pharmacies matter more than the lowest price, see RxSpan MD; if oral and injectable formats both matter and no-fee simplicity appeals to you, compare DudeMeds. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through MadeMed?

On this provider, MadeMed prices compounded tirzepatide at $399/month on a quarterly plan or from $369/month on a six-month plan, the same price at every dose from 2.5mg to 15mg. This review's own live pass could not independently reconfirm those figures because MadeMed's product page renders pricing client-side — confirm directly on mademed.com.

Is MadeMed's LegitScript certification genuine?

The checker link is genuine and domain-specific to mademed.com. The badge image itself, however, is self-hosted on MadeMed's own server rather than served from LegitScript's own CDN — a weaker technical signal. Click through the checker link yourself to confirm current status rather than trusting the badge image alone.

Does MadeMed offer oral tirzepatide?

Yes — MadeMed offers both injectable and oral tirzepatide routes, one of relatively few programs in this category to offer the molecule without a needle as a stated option.

What happens if I'm not prescribed by MadeMed?

On this provider, MadeMed refunds everything except a stated $39 physician-visit fee if you are not prescribed — disclosed before checkout rather than buried in terms. Confirm this directly with MadeMed, as this review's live pass could not independently reconfirm the figure.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.